Odyssean LLC’s Atrium Therapeutics RNA Stock Holding History
Bought
Maintained
Sold
Other funds holding RNA
Odyssean LLC's RNA Position: Q3 2026 in Review
Odyssean LLC sold out of Atrium Therapeutics (RNA) in Q3 2026, closing a stake of 21,233 shares — an estimated $286K sold.
Odyssean LLC first reported a position in RNA in Q2 2026 and held it in 1 quarter. The position peaked at $286K in Q2 2026. 148 funds tracked by Wall St. Rank hold RNA as of Q3 2026.
- Odyssean LLC reported no remaining Atrium Therapeutics position as of Q3 2026 after selling out during the quarter.
- Odyssean LLC sold 21,233 Atrium Therapeutics shares in Q3 2026, an estimated $286K.
- Odyssean LLC first reported a position in Atrium Therapeutics in Q2 2026 and held it in 1 quarter.
- Odyssean LLC's Atrium Therapeutics position peaked at $286K in Q2 2026.
- 148 funds tracked by Wall St. Rank held Atrium Therapeutics as of Q3 2026.
Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.